Concomitant/JJ
downregulation/NN
of/IN
IgH/NN
3'/JJ
enhancer/NN
activity/NN
and/CC
c-myc/NN
expression/NN
in/IN
a/DT
plasmacytoma/NN
x/NN
fibroblast/NN
environment/NN
:/:
implications/NNS
for/IN
dysregulation/NN
of/IN
translocated/VBN
c-myc/NN
./.

Regulation/NN
of/IN
immunoglobulin/NN
heavy/JJ
chain/NN
(/(
IgH/NN
)/)
gene/NN
expression/NN
is/VBZ
controlled/VBN
by/IN
a/DT
B/NN
cell-specific/JJ
promoter/NN
,/,
intronic/JJ
enhancer/NN
and/CC
additional/JJ
B/NN
cell-specific/JJ
enhancer/NN
elements/NNS
identified/VBN
recently/RB
in/IN
the/DT
3'/JJ
end/NN
of/IN
the/DT
IgH/NN
locus/NN
./.
=====
One/CD
of/IN
the/DT
latter/JJ
elements/NNS
,/,
the/DT
IgH/NN
3'/JJ
enhancer/NN
,/,
is/VBZ
of/IN
particular/JJ
interest/NN
:/:
(/(
1/LS
)/)
it/PRP
is/VBZ
B/NN
cell-specific/JJ
and/CC
active/JJ
only/RB
in/IN
late/JJ
B/NN
cell/NN
development/NN
;/:
(/(
2/LS
)/)
in/IN
rodent/JJ
plasmacytomas/NNS
and/CC
in/IN
some/DT
human/JJ
Burkitt/NN
's/POS
lymphomas/NNS
it/PRP
is/VBZ
part/NN
of/IN
a/DT
locus/NN
control/NN
region/NN
(/(
LCR/NN
)/)
that/WDT
is/VBZ
involved/VBN
in/IN
deregulation/NN
of/IN
the/DT
c-myc/NN
oncogene/NN
as/IN
a/DT
result/NN
of/IN
translocation/NN
into/IN
the/DT
IgH/NN
locus/NN
;/:
and/CC
(/(
3/LS
)/)
it/PRP
has/VBZ
been/VBN
implicated/VBN
in/IN
the/DT
mechanisms/NNS
that/WDT
control/VBP
Ig/NN
gene/NN
class/NN
switch/NN
recombination/NN
./.
=====
We/PRP
have/VBP
used/VBN
a/DT
somatic/JJ
cell/NN
hybridization/NN
approach/NN
to/TO
genetically/RB
analyse/VB
regulation/NN
of/IN
the/DT
activity/NN
of/IN
the/DT
IgH/NN
3'/JJ
enhancer/NN
./.
=====
When/WRB
mouse/NN
MPC11/NN
plasmacytoma/NN
cells/NNS
,/,
in/IN
which/WDT
the/DT
IgH/NN
3'/JJ
enhancer/NN
is/VBZ
active/JJ
,/,
are/VBP
fused/VBN
with/IN
fibroblasts/NNS
,/,
Ig/NN
expression/NN
is/VBZ
extinguished/VBN
at/IN
the/DT
level/NN
of/IN
transcription/NN
./.
=====
Here/RB
we/PRP
show/VBP
that/IN
in/IN
a/DT
MPC11/NN
plasmacytoma/NN
x/NN
fibroblast/NN
environment/NN
,/,
the/DT
IgH/NN
3'/JJ
enhancer/NN
is/VBZ
transcriptionally/RB
inactive/JJ
./.
=====
Furthermore/RB
,/,
we/PRP
demonstrate/VBP
that/IN
binding/NN
of/IN
several/JJ
B/NN
cell-specific/JJ
transcription/NN
factors/NNS
,/,
essential/JJ
for/IN
IgH/NN
3'/JJ
enhancer/NN
activity/NN
,/,
is/VBZ
lacking/VBG
,/,
which/WDT
may/MD
explain/VB
3'/JJ
enhancer/NN
inactivity/NN
,/,
although/IN
the/DT
binding/NN
of/IN
repressors/NNS
can/MD
not/RB
be/VB
excluded/VBN
./.
=====
Moreover/RB
,/,
the/DT
high/JJ
expression/NN
level/NN
of/IN
c-myc/NN
,/,
characteristic/JJ
of/IN
the/DT
parental/JJ
MPC11/NN
cells/NNS
carrying/VBG
the/DT
t(12;15)/NN
translocation/NN
,/,
is/VBZ
down-regulated/VBN
in/IN
the/DT
hybrids/NNS
to/TO
that/DT
in/IN
unfused/JJ
fibroblasts/NNS
./.
=====
Therefore/RB
,/,
inactivation/NN
of/IN
the/DT
IgH/NN
3'/JJ
enhancer/NN
is/VBZ
a/DT
multifactorial/JJ
process/NN
affecting/VBG
several/JJ
transcription/NN
factors/NNS
that/WDT
control/VBP
the/DT
cell-specific/JJ
and/CC
developmental/JJ
activity/NN
of/IN
the/DT
enhancer/NN
./.